Sionna Therapeutics, Inc. (SION)
42.80
+1.08
(+2.58%)
USD |
NASDAQ |
Dec 12, 16:00
44.00
+1.20
(+2.82%)
After-Hours: 20:00
Sionna Therapeutics Total Liabilities (Quarterly): 17.60M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 834.31M |
| Orthofix Medical, Inc. | 390.12M |
| Pacira Biosciences, Inc. | 570.36M |
| Viridian Therapeutics, Inc. | 74.17M |
| Astria Therapeutics, Inc. | 38.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 339.27M |
| Shareholders Equity (Quarterly) | 321.67M |
| Debt to Equity Ratio | 0.0279 |
| Current Ratio | 25.61 |
| Net Debt Paydown Yield | -0.14% |